FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

FDA Posts Annual Report on Postmarketing Study Requirements

Federal Register notice: FDA posts its annual report on the status of drug/biologic postmarketing requirements and postmarketing commitments.

Medical Devices

FDA Clears Genea Biomedx Benchtop Incubator

FDA clears a Genea Biomedx 510(k) for its benchtop incubator Geri.

Human Drugs

WLF Urges FDA to Replace Guidances with Rulemaking

The Washington Legal Foundation urges FDA to replace all older guidances with formal regulations that undergo a notice-and-comment rulemaking process.

Human Drugs

Comment Period Extended on Synthetic Peptide Guide

Federal Register notice: FDA extends the comment period on a 10/3 draft guidance entitled ANDAs for Certain Highly Purified Synthetic Peptide Drug Pro...

FDA General

Gottlieb: Science Contributing to Inflection Point in Medicine

FDA commissioner Scott Gottlieb says that across multiple science fields, we stand at an inflection point in medicine where new technology is creatin...

Marketing

Avanir Paid Disciplined Doctors to Promote Nudexta: CNN

CNN says Avanir has paid some doctors facing disciplinary measures or criminal charges to promote its Nudexta.

Human Drugs

Drug Spending Increase Lower than Last 2 Years: Report

Federal actuaries say the annual increase in spending on prescription drugs nationally was lower in 2016 than in the previous two years.

Medical Devices

FDA Expands Digital Health Efforts: Gottlieb

FDA commissioner Scott Gottlieb announces three new guidances to expand the agencys digital health efforts under the 21st Century Cures Act.

Human Drugs

Duke Launches Real-World Evidence Collaborative

The Duke Margolis Center for Health Policy announces a new Real-World Evidence Collaborative to support FDA in meeting real-world evidence milestones ...

Medical Devices

Bayer Rebuts DeLauro Complaint on Essure Study

Bayer vice president Steven Immergut disputes a complaint by Rep. Rosa DeLauro (D-CT) that the company has enrolled only one patient in an FDA-require...